Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old

Human papillomavirus (HPV) infection can lead to significant disease in males, including anogenital warts, intraepithelial neoplasias, and several types of oral and anogenital cancers. The quadrivalent HPV (type 6/11/16/18) L1 virus-like particle (VLP) vaccine (qHPV vaccine; Gardasil) has recently b...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hillman, Richard J., Giuliano, Anna R., Palefsky, Joel M., Goldstone, Stephen, Moreira, Edson D., Vardas, Eftyhia, Aranda, Carlos, Jessen, Heiko, Ferris, Daron G., Coutlee, Francois, Marshall, J. Brooke, Vuocolo, Scott, Haupt, Richard M., Guris, Dalya, Garner, Elizabeth I. O.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2012
Pynciau:
Vaccines
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3272915/
https://ncbi.nlm.nih.gov/pubmed/22155768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.05208-11
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg